TransUnion — Director's Dealing 2020

Feb 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransUnion (TRU)
CIK: 0001552033
Period of Report: 2020-02-21

Reporting Person: WOJCZYNSKI DAVID E (President, Healthcare)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-21	Common Stock	A	3593	—	Acquired	35357	Direct
2020-02-21	Common Stock	M	1800	$8.57	Acquired	37157	Direct
2020-02-21	Common Stock	S	9053	$100	Disposed	28104	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Stock Options (right to buy)	$8.57	M	1800	Disposed	2024-04-01	Common Stock (1800.0)	Direct

Footnotes

F1: Represents a grant of restricted stock units that vest ratably over three years, i.e., 33% on the first anniversary of the date of grant, 33% on the second anniversary of the date of grant, and 34% on the third anniversary of the date of grant.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3: Represents an initial grant of 35,990 stock options, 40% of which vest upon the attainment of time-based vesting criteria and 60% of which vest upon the attainment of both time-based and performance-based vesting criteria. The performance-based vesting criteria was satisfied on February 22, 2017, and all options now follow the time-based vesting criteria as follows: 20% on the first anniversary of the date of grant and 5% on the last day of each subsequent full calendar quarter.